Alvotech to invests $250M in the development of biosimilar monoclonal antibodies Alvotech, a powerful new player in the field of biopharmaceuticals, today announced plans to invest $250 million in the development and manufacturing of a portfolio of biosimilar monoclonal antibodies http://orlistatindia.com click here . Alvotech's current biosimilar assets include follow-on versions of leading monoclonal antibodies molecules, which will be taken to market by 2018. Headquartered in Reykjavik, Iceland, Alvotech can be an independent sister firm of the multinational pharmaceuticals organization, Alvogen. Alvogen currently markets biosimilars in selected regions through alliances with various other companies including Hospira and offers many pending marketing authorizations worldwide. Related StoriesLiposomal sizing and the Coulter basic principle: an interview with Professor Melvin E. KlegermanMagnetizing biomolecules: an interview with Dr. Andrew Ward ‘At Alvotech we are motivated to help patients all over the world by increasing the accessibility and affordability of high quality biopharmaceuticals,’ stated Dr. Andreas Herrmann, CEO of Alvotech, ‘By merging Alvotech's development and production excellence with Alvogen's global marketing platform, we are taking a significant step toward becoming a major player in the biopharmaceutical market and bringing valuable expense to support our growth.in November ‘ Alvotech broke ground, 2013 on a fresh 11,800sqm advancement and manufacturing facility, where it shall generate its own developed biosimilars, the first of which already are in advanced development stage . Situated in the science recreation area of the University of Iceland in Reykjavik, the website provides Alvotech with an ongoing state of the artwork, fully vertically integrated biologics manufacturing plant. Iceland is a favorable location supplying a strong regulatory system, low operating costs, an excellent talent pool, top quality requirements and a easy geographical location between your EU and US that is within easy reach of the rest of the world. ‘Most of the world's top-selling medications are biologics, and exposure to biopharmaceuticals has become an important development engine for Alvogen. The alliance with Alvotech allows us to leverage our global industrial network in over 30 countries and can be an important step for both companies towards getting leaders in the biopharmaceutical industry. The partnership is definitely a valuable addition to your current biosimilar business,’ said Robert Wessman, Chairman and CEO of Alvogen. Dr. Andreas Herrmann leads the Alvotech management team and brings 25 years of industry encounter. Prior to joining Alvotech, Dr. Herrmann offered as the CEO of Baliopharm AG and Celonic in Switzerland. In 1994, he received his PhD in biochemistry in neurobiology and joined the University of Cologne as a co-employee professor in the department of cardiovascular physiology. Since 1996, he has been the co-founder and CEO of four biotechnology companies.
Alzheimer’s disease: What you eat influences your risk factor You may be able to lower your threat of Alzheimer’s disease, if you incorporate some special foods into your daily diet, according to a new reserve.’Power Foods for the Brain: A HIGHLY EFFECTIVE Three Step Intend to Protect Your Mind and Strengthen Your Storage.’ ‘There’s nothing even more frightening than losing your memory as well as your connections. A lot of people have thought, well, it’s just part of aging and I’m going to spend the last five or 10 years of my life not knowing anybody,’ stated Dr. Neal Barnard, author of ‘Power Foods for the mind: A HIGHLY EFFECTIVE Three Step Intend to Protect YOUR BRAIN and Strengthen Your Memory.’ ‘The stunning news is we now know what appears to be triggering that so that we are able to avoid it.’ He advises that there are many foods in order to avoid, including avoiding trans-body fat and fats. These fats aren’t only harmful to your heart, but can increase your chance for Alzheimer’s 300 to 500 % for those who eat the most. He also suggests avoiding using particular metals in cookware. Number of Alzheimer’s sufferers could triple by 2050 ‘For those who have a cast iron pan, over time it shall rust. That’s oxidation, and that occurs to the metals that get into your body. So a trace is needed by you of iron for healthy bloodstream cells, but iron builds up in the oxidizes and mind,’ explains Barnard, a nourishment researcher at George Washington University. ‘That releases free of charge radicals, and destroys human brain cells. Therefore a stainless steel pan is preferable to a cast iron pan.’ However, there are also many foods that actually help ward off the disease. Barnard suggests eating large amounts of dark berries and leafy greens, as those foods help out with maintaining your brain healthy. It is also helpful to eat almonds and other food stuffs with high levels of vitamin E. People who got the most supplement E had 60 % less risk for Alzheimer’s compared to other people. Alzheimer’s: Families face hard healthcare decisions ‘Everybody should be concentrating on vegetables, fruits, wholegrains, beans. When people look at vegetarians, they longer live, they have less heart disease and it looks like an edge is had by them in mental health, aswell. There is less risk of dementia,’ said Barnard. It’s not just what you put in the body that can help, but what you do with it also. Barnard shows that exercising and obtaining enough sleep can help keep the human brain functioning by raising the circulation of oxygen. ‘Researchers have shown even 30 to 40 minutes of exercise, a brisk walk 3 x a full week, changes the mind physically,’ he said. For Dr. Bernard’s full interview, view the video in the player above. >.